Novartis Inks $390M FCA Deal Over Pharmacy Discounts
Novartis AG on Tuesday said it has tentatively agreed to shell out $390 million to end a whistleblower's False Claims Act suit alleging improper kickbacks to pharmacies to boost sales of...To view the full article, register now.
Already a subscriber? Click here to view full article